Local Leadership

Christopher Stokes

Christopher Stokes was appointed President and General Manager (GM) of Eli Lilly and Company UK, Ireland & Northern Europe in July 2024. Christopher leads Lilly’s commercial business operations in six countries, across the company’s current and emerging portfolio in Diabetes, Obesity, Oncology, Immunology and Neuroscience. Christopher joined the UK from his previous role as General Manager of Lilly Korea, where he led the Korean affiliate to strong business results driven by new product growth.

Christopher has been at Lilly since 2008 and has held roles as GM of Lilly South Africa and Sub-Saharan Africa, and COO of Lilly USA. He has built a reputation for expertise in the global regulatory landscape and an unfaltering commitment to patient access to innovative medicines to enhance health and enrich quality of life. He has a “better to best” mindset and brings a focus on delivering results while building and engaging strong teams with high integrity. Christopher holds a Bachelor’s degree from George Mason University and a Master’s in Public Administration from Indiana University-Bloomington.

Emily Pegg

Dr Emily Pegg has a decade of experience in the pharmaceutical industry, starting at Novartis, where for 5 years she worked in both UK and regional roles in its Neuroscience franchise. In late 2018, Emily moved to Shire shortly before its acquisition by Takeda, where she was the Country Medical Lead for Genetic Diseases and later Head of Medical Affairs for Oncology.

Most recently, Emily held the role of Associate Medical Director for Takeda UK and Ireland before moving to Lilly in 2023 to take up the role of Associate VP – Medical, Northern European Hub. Prior to her career in the pharmaceutical industry Emily trained as a clinical doctor in the NHS and is a Member of the Faculty of Pharmaceutical Medicine.

Lisa Broad

Lisa Broad PhD is Vice President and Head of Neurodegeneration Discovery Research Lilly, she is also Managing Director of Lilly Research Labs in the UK.

Lisa is a physiologist/pharmacologist by training with 24 years of industrial experience focused on discovery and development of novel therapeutics in the Neuroscience area.

Prior to joining Lilly, Lisa completed post-doctoral studies at the National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, USA and the University of Cambridge. Lisa received her doctorate from the University of Cambridge.